CUSIP: 464287325
Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
46,341,458
-
Total 13F shares
-
31,806,997
-
Share change
-
+994,056
-
Total reported value
-
$2,900,921,711
-
Price per share
-
$91.20
-
Number of holders
-
263
-
Value change
-
+$92,094,642
-
Number of buys
-
81
-
Number of sells
-
111
Security key
464287325
Report period
Q1 2025
Institutions
263
Top holders
10
Reporting periods
Holder history for CUSIP 464287325
Recent filing periods:
Top shareholders of IXJ - ISHARES GLOBAL HEALTHCARE ETF - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.
Institutional Holders of ISHARES GLOBAL HEALTHCARE ETF - Common Stock (IXJ) as of Q1 2025
As of 31 Mar 2025,
ISHARES GLOBAL HEALTHCARE ETF - Common Stock (IXJ) was held by
263 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
31,806,997 shares.
The largest 10 holders included
BlackRock, Inc., Fisher Asset Management, LLC, BANK OF AMERICA CORP /DE/, Richard Bernstein Advisors LLC, Phoenix Financial Ltd., JPMORGAN CHASE & CO, MORGAN STANLEY, UBS Group AG, Federation des caisses Desjardins du Quebec, and ROYAL BANK OF CANADA.
This page lists
265
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
Compare Q1 2025 vs Q4 2024 Across Filers
| Investor |
Q4 2024 Shares |
Q1 2025 Shares |
Share Diff |
Share Chg % |
Q4 2024 Value $ |
Q1 2025 Value $ |
Value Diff $ |
Value Chg % |
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.